◆ 会议时间:2023年8月21日至23日
◆ 会议地点:肯尼亚 蒙巴萨
◆ 会议简介:
2023年国际眼科肿瘤学会(ISOO)非洲大会将于2023年8月21日至23日在肯尼亚蒙巴萨举行。
国际眼科肿瘤学会(ISOO)成立于2004年,是一个旨在推动和促进眼科肿瘤学实践的非盈利性组织,ISOO每两年主办一次国际眼科肿瘤学大会。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com).
ISOO AFRICA 2023 - International Society of Ocular Oncology
Date: August 21 - 23, 2023
Venue: Mombasa, Kenya
摘要征集:
15 March 2023:
Abstract Submission Deadline
April 2023:
Abstract Notifications
Submit your Abstract
Please read the submission rules before submitting an abstract.
- Abstracts must be submitted online via the website only.
ABSTRACTS SUBMITTED BY EMAIL WILL NOT BE ACCEPTED.
- Presentation Type: Abstracts may be submitted for oral or poster presentation. The Scientific Abstracts Committee will determine whether the abstract will be accepted for presentation, with consideration given to the author’s preference.
- Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
Limitations:
- The same person may serve as first and presenting author on up to one oral and one poster presentation.
- Presenting authors must be registered participants. Only abstracts of authors who have paid their registration fees by June 1, 2023 will be scheduled for presentation.
- The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.
- Abstracts must be submitted in English.
All abstracts should be submitted and presented in clear English with accurate grammar and spelling. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university specific publications office (or other similar facility) or by a copy editor, prior to submission.
- Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.
Instructions for preparation of presentations will be made available on the congress website.
Guidelines for Submission
Before you begin, please prepare the following information:
- Presenting author’s contact details:
– Full first and family name(s)
– Email address
– Affiliation details: department, institution / hospital, city, state (if applicable), country
– Phone number
- Author and co-authors’ details
- Preferred Presentation type: Oral/Poster presentation
- Abstract title –Limited to 25 words. Please submit symbols as words.
- Abstract text – limited to 250 words. Abstracts will include only text. Images and/or tables are not allowed.
- Abstracts should clearly state:
Background
Methods
Results
Conclusions
- Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
- Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
- Submissions may not contain patient names, hospital ID numbers or other identifying information.
- Click on the SUBMIT button at the end of the process in order to submit your abstract.
- You will receive an abstract ID number via email after you have submitted your abstract. Please refer to this abstract number in all correspondence regarding the abstract.
- Please contact us if you have not received confirmation that your abstract has been submitted.
- Please do not submit multiple copies of the same abstract.
Abstract Submitters' Declaration
During abstract submission you will be asked to confirm that you agree to the following:
- I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published as submitted.
- Submission of the abstract constitutes the consent of all authors to publication (e.g. congress website, programs, other promotions, etc.)
- The Abstract Submitter warrants and represents that no part of the information and content provided by him/her (Hereafter: the “Content“) to ISOO Africa 2023 and Kenes Israel (Hereafter: the “Organizers“), nor the publication of any such Content by the Organizers, on the internet or otherwise infringes any third party rights, including but not limited to privacy rights and/or intellectual property rights.
- The Abstract Submitter grants the Organizers a copyright license to reproduce, publish, translate, distribute, and display the text of the Content on a royalty-free, perpetual, irrevocable nonexclusive basis.
- I herewith confirm that the contact details saved in this system are those of the presenting author, who will be notified about the status of the abstract. The presenting author is responsible for informing the other authors about the status of the abstract. The submitting author may request to be copied on abstract correspondence.
- I understand that the presenting author must be a registered participant.
- The Organizers reserve the right to remove from publication and/or presentation an abstract which does not comply with the above.
- I understand that I must select a specific Topic for my abstract allocation. Although the Committee will work hard to honor this. selection, this cannot be guaranteed. The Committee reserves the right to change the Topic under which the abstract was originally submitted.
WELCOME
On behalf of the International Society of Ocular Oncology, we are delighted to welcome you to the very First Meeting of the International Society of Ocular Oncology in Africa. This unique event is scheduled to take place in Mombasa, Kenya, from August 21 to 23, 2023. ISOO Africa will precede the Annual College of Ophthalmology of Eastern Central and Southern Africa (COECSA) Conference scheduled on August 23-25, 2023 at the same location. With the loosening of the world’s COVID restrictions we are now able to bring you this unique, fully physical Meeting. A chance to connect with colleagues from around the region as well as peers from other continents. For those that are not able to attend this meeting in person we are working on a virtual option for the sessions. Africa presents unique challenges in the field of ocular oncology; this inaugural event will have an exciting program with distinguished speakers both from the region and the rest of the world. ISOO Africa will cover the most pressing topics in Ocular Oncology facing the African Continent. In this region Uveal melanoma is considered somewhat rare, but Retinoblastoma is found to be relatively common due to high birth rates and large populations. Conjunctival tumors are also common, especially ocular surface squamous neoplasia (OSSN) and, like retinoblastoma, many cases are diagnosed late posing difficulties in management and resulting in a poor prognosis. These topics will be discussed in detail during ISOO AFRICA 2023 with lectures from international and regional speakers, case study presentations, and oral presentations from abstract submissions. Join us to discuss and learn about these specific challenges in the field of ocular oncology in the African continent!
Ido Didi Fabian, MD
Israel
Laurence Desjardins, MD
France
Kahaki Kimani, MD
Kenya
注册费:
Registration Fees ISOO Africa 2023
Register |
Early Bird (in USD)
1st January 2023 – 30th April 2023 |
Regular Registration (in USD)
1st May 2023 – 31st July 2023 |
Onsite Registration (in USD)
1st August 2023 |
Resident/Doctor in training from Low and Lower- Middle Income Countries* |
$100 |
$150 |
$200 |
Doctors from Low and Lower- Middle Income Countries* |
$150 |
$200 |
$250 |
ISOO Members |
$200 |
$250 |
$300 |
Non-ISOO Members (International) |
$250 |
$300 |
$350 |
Residents /Doctors in training |
$150 |
$200 |
$250 |
Pediatric Oncologists |
$150 |
$200 |
$250 |
Pathologists |
$50 |
$100 |
$150 |
Allied Health Professionals |
$100 |
$150 |
$200 |
Attending COECSA 2023 |
$100 |
$150 |
$200 |
* Low and Lower-Middle income countries are determined by the World Bank; to see the most updated list of countries according to their classification please click here.
Fees for International Participants Include:
- Admission to all program sessions and poster area
- Access to the commercial exhibition
- Congress printed materials
- Refreshments at breaks as indicated in the program
- Certificate of Attendance (sent via email after the congress)
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|